Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Neutropenia Biologic Drug Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neutropenia Biologic Drug Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neutropenia Biologic Drug Treatment Overall Market Size
2.1 Global Neutropenia Biologic Drug Treatment Market Size: 2021 VS 2028
2.2 Global Neutropenia Biologic Drug Treatment Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Neutropenia Biologic Drug Treatment Sales: 2017-2028
3 Company Landscape
3.1 Top Neutropenia Biologic Drug Treatment Players in Global Market
3.2 Top Global Neutropenia Biologic Drug Treatment Companies Ranked by Revenue
3.3 Global Neutropenia Biologic Drug Treatment Revenue by Companies
3.4 Global Neutropenia Biologic Drug Treatment Sales by Companies
3.5 Global Neutropenia Biologic Drug Treatment Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Neutropenia Biologic Drug Treatment Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Neutropenia Biologic Drug Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Neutropenia Biologic Drug Treatment Players in Global Market
3.8.1 List of Global Tier 1 Neutropenia Biologic Drug Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Neutropenia Biologic Drug Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Neutropenia Biologic Drug Treatment Market Size Markets, 2021 & 2028
4.1.2 Filgrastim
4.1.3 Pegfilgrastim
4.1.4 Lenograstim
4.1.5 Lipegfilgrastim
4.1.6 Sargramostim
4.2 By Type - Global Neutropenia Biologic Drug Treatment Revenue & Forecasts
4.2.1 By Type - Global Neutropenia Biologic Drug Treatment Revenue, 2017-2022
4.2.2 By Type - Global Neutropenia Biologic Drug Treatment Revenue, 2023-2028
4.2.3 By Type - Global Neutropenia Biologic Drug Treatment Revenue Market Share, 2017-2028
4.3 By Type - Global Neutropenia Biologic Drug Treatment Sales & Forecasts
4.3.1 By Type - Global Neutropenia Biologic Drug Treatment Sales, 2017-2022
4.3.2 By Type - Global Neutropenia Biologic Drug Treatment Sales, 2023-2028
4.3.3 By Type - Global Neutropenia Biologic Drug Treatment Sales Market Share, 2017-2028
4.4 By Type - Global Neutropenia Biologic Drug Treatment Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Neutropenia Biologic Drug Treatment Market Size, 2021 & 2028
5.1.2 Retail Pharmacies
5.1.3 Hospital Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Neutropenia Biologic Drug Treatment Revenue & Forecasts
5.2.1 By Application - Global Neutropenia Biologic Drug Treatment Revenue, 2017-2022
5.2.2 By Application - Global Neutropenia Biologic Drug Treatment Revenue, 2023-2028
5.2.3 By Application - Global Neutropenia Biologic Drug Treatment Revenue Market Share, 2017-2028
5.3 By Application - Global Neutropenia Biologic Drug Treatment Sales & Forecasts
5.3.1 By Application - Global Neutropenia Biologic Drug Treatment Sales, 2017-2022
5.3.2 By Application - Global Neutropenia Biologic Drug Treatment Sales, 2023-2028
5.3.3 By Application - Global Neutropenia Biologic Drug Treatment Sales Market Share, 2017-2028
5.4 By Application - Global Neutropenia Biologic Drug Treatment Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Neutropenia Biologic Drug Treatment Market Size, 2021 & 2028
6.2 By Region - Global Neutropenia Biologic Drug Treatment Revenue & Forecasts
6.2.1 By Region - Global Neutropenia Biologic Drug Treatment Revenue, 2017-2022
6.2.2 By Region - Global Neutropenia Biologic Drug Treatment Revenue, 2023-2028
6.2.3 By Region - Global Neutropenia Biologic Drug Treatment Revenue Market Share, 2017-2028
6.3 By Region - Global Neutropenia Biologic Drug Treatment Sales & Forecasts
6.3.1 By Region - Global Neutropenia Biologic Drug Treatment Sales, 2017-2022
6.3.2 By Region - Global Neutropenia Biologic Drug Treatment Sales, 2023-2028
6.3.3 By Region - Global Neutropenia Biologic Drug Treatment Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Neutropenia Biologic Drug Treatment Revenue, 2017-2028
6.4.2 By Country - North America Neutropenia Biologic Drug Treatment Sales, 2017-2028
6.4.3 US Neutropenia Biologic Drug Treatment Market Size, 2017-2028
6.4.4 Canada Neutropenia Biologic Drug Treatment Market Size, 2017-2028
6.4.5 Mexico Neutropenia Biologic Drug Treatment Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Neutropenia Biologic Drug Treatment Revenue, 2017-2028
6.5.2 By Country - Europe Neutropenia Biologic Drug Treatment Sales, 2017-2028
6.5.3 Germany Neutropenia Biologic Drug Treatment Market Size, 2017-2028
6.5.4 France Neutropenia Biologic Drug Treatment Market Size, 2017-2028
6.5.5 U.K. Neutropenia Biologic Drug Treatment Market Size, 2017-2028
6.5.6 Italy Neutropenia Biologic Drug Treatment Market Size, 2017-2028
6.5.7 Russia Neutropenia Biologic Drug Treatment Market Size, 2017-2028
6.5.8 Nordic Countries Neutropenia Biologic Drug Treatment Market Size, 2017-2028
6.5.9 Benelux Neutropenia Biologic Drug Treatment Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Neutropenia Biologic Drug Treatment Revenue, 2017-2028
6.6.2 By Region - Asia Neutropenia Biologic Drug Treatment Sales, 2017-2028
6.6.3 China Neutropenia Biologic Drug Treatment Market Size, 2017-2028
6.6.4 Japan Neutropenia Biologic Drug Treatment Market Size, 2017-2028
6.6.5 South Korea Neutropenia Biologic Drug Treatment Market Size, 2017-2028
6.6.6 Southeast Asia Neutropenia Biologic Drug Treatment Market Size, 2017-2028
6.6.7 India Neutropenia Biologic Drug Treatment Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Neutropenia Biologic Drug Treatment Revenue, 2017-2028
6.7.2 By Country - South America Neutropenia Biologic Drug Treatment Sales, 2017-2028
6.7.3 Brazil Neutropenia Biologic Drug Treatment Market Size, 2017-2028
6.7.4 Argentina Neutropenia Biologic Drug Treatment Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Neutropenia Biologic Drug Treatment Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Neutropenia Biologic Drug Treatment Sales, 2017-2028
6.8.3 Turkey Neutropenia Biologic Drug Treatment Market Size, 2017-2028
6.8.4 Israel Neutropenia Biologic Drug Treatment Market Size, 2017-2028
6.8.5 Saudi Arabia Neutropenia Biologic Drug Treatment Market Size, 2017-2028
6.8.6 UAE Neutropenia Biologic Drug Treatment Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Amgen
7.1.1 Amgen Corporate Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Neutropenia Biologic Drug Treatment Major Product Offerings
7.1.4 Amgen Neutropenia Biologic Drug Treatment Sales and Revenue in Global (2017-2022)
7.1.5 Amgen Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Neutropenia Biologic Drug Treatment Major Product Offerings
7.2.4 Novartis Neutropenia Biologic Drug Treatment Sales and Revenue in Global (2017-2022)
7.2.5 Novartis Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Neutropenia Biologic Drug Treatment Major Product Offerings
7.3.4 Pfizer Neutropenia Biologic Drug Treatment Sales and Revenue in Global (2017-2022)
7.3.5 Pfizer Key News
7.4 Baxter International
7.4.1 Baxter International Corporate Summary
7.4.2 Baxter International Business Overview
7.4.3 Baxter International Neutropenia Biologic Drug Treatment Major Product Offerings
7.4.4 Baxter International Neutropenia Biologic Drug Treatment Sales and Revenue in Global (2017-2022)
7.4.5 Baxter International Key News
7.5 Cellerant Therapeutics
7.5.1 Cellerant Therapeutics Corporate Summary
7.5.2 Cellerant Therapeutics Business Overview
7.5.3 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Major Product Offerings
7.5.4 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Sales and Revenue in Global (2017-2022)
7.5.5 Cellerant Therapeutics Key News
7.6 Dong-A ST Co.,Ltd.
7.6.1 Dong-A ST Co.,Ltd. Corporate Summary
7.6.2 Dong-A ST Co.,Ltd. Business Overview
7.6.3 Dong-A ST Co.,Ltd. Neutropenia Biologic Drug Treatment Major Product Offerings
7.6.4 Dong-A ST Co.,Ltd. Neutropenia Biologic Drug Treatment Sales and Revenue in Global (2017-2022)
7.6.5 Dong-A ST Co.,Ltd. Key News
7.7 Myelo Therapeutics GmbH
7.7.1 Myelo Therapeutics GmbH Corporate Summary
7.7.2 Myelo Therapeutics GmbH Business Overview
7.7.3 Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Major Product Offerings
7.7.4 Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Sales and Revenue in Global (2017-2022)
7.7.5 Myelo Therapeutics GmbH Key News
7.8 Sanofi
7.8.1 Sanofi Corporate Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Neutropenia Biologic Drug Treatment Major Product Offerings
7.8.4 Sanofi Neutropenia Biologic Drug Treatment Sales and Revenue in Global (2017-2022)
7.8.5 Sanofi Key News
7.9 Teva Pharmaceutical Industries Ltd.
7.9.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
7.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.9.3 Teva Pharmaceutical Industries Ltd. Neutropenia Biologic Drug Treatment Major Product Offerings
7.9.4 Teva Pharmaceutical Industries Ltd. Neutropenia Biologic Drug Treatment Sales and Revenue in Global (2017-2022)
7.9.5 Teva Pharmaceutical Industries Ltd. Key News
7.10 Kyowa Kirin
7.10.1 Kyowa Kirin Corporate Summary
7.10.2 Kyowa Kirin Business Overview
7.10.3 Kyowa Kirin Neutropenia Biologic Drug Treatment Major Product Offerings
7.10.4 Kyowa Kirin Neutropenia Biologic Drug Treatment Sales and Revenue in Global (2017-2022)
7.10.5 Kyowa Kirin Key News
7.11 CVS Health
7.11.1 CVS Health Corporate Summary
7.11.2 CVS Health Neutropenia Biologic Drug Treatment Business Overview
7.11.3 CVS Health Neutropenia Biologic Drug Treatment Major Product Offerings
7.11.4 CVS Health Neutropenia Biologic Drug Treatment Sales and Revenue in Global (2017-2022)
7.11.5 CVS Health Key News
7.12 Partner Therapeutics
7.12.1 Partner Therapeutics Corporate Summary
7.12.2 Partner Therapeutics Neutropenia Biologic Drug Treatment Business Overview
7.12.3 Partner Therapeutics Neutropenia Biologic Drug Treatment Major Product Offerings
7.12.4 Partner Therapeutics Neutropenia Biologic Drug Treatment Sales and Revenue in Global (2017-2022)
7.12.5 Partner Therapeutics Key News
7.13 Enzychem Lifesciences Corporation
7.13.1 Enzychem Lifesciences Corporation Corporate Summary
7.13.2 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Business Overview
7.13.3 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Major Product Offerings
7.13.4 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Sales and Revenue in Global (2017-2022)
7.13.5 Enzychem Lifesciences Corporation Key News
8 Global Neutropenia Biologic Drug Treatment Production Capacity, Analysis
8.1 Global Neutropenia Biologic Drug Treatment Production Capacity, 2017-2028
8.2 Neutropenia Biologic Drug Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Neutropenia Biologic Drug Treatment Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Neutropenia Biologic Drug Treatment Supply Chain Analysis
10.1 Neutropenia Biologic Drug Treatment Industry Value Chain
10.2 Neutropenia Biologic Drug Treatment Upstream Market
10.3 Neutropenia Biologic Drug Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Neutropenia Biologic Drug Treatment Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer